Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEL
1151
DELISTED
Stellar Bancorp
STEL
| $11.3M | 0.02% |
348,718
-31,298
| -8% | -$1.01M |
|
1152
CALL
Boston Scientific
BSX
$71B
| $11.3M | 0.02% |
+295,000
| New | +$11.3M |
|
1153
Box
BOX
$4.64B
| $11.3M | 0.02% |
584,538
-612,150
| -51% | -$12.7M |
|
1154
Protagonist Therapeutics
PTGX
$10B
| $11.2M | 0.02% |
893,155
+203,004
| +29% | +$1.79M |
|
|
SIX
1155
DELISTED
Six Flags Entertainment Corp.
SIX
| $11.2M | 0.02% |
227,438
-541,666
| -70% | -$30.6M |
|
1156
Greif
GEF
$4.89B
| $11.2M | 0.02% |
271,554
+112,100
| +70% | +$4.48M |
|
|
AXNX
1157
DELISTED
Axonics, Inc. Common Stock
AXNX
| $11.2M | 0.02% |
467,250
-331,700
| -42% | -$6.02M |
|
1158
CALL
Baxter International
BAX
$13.7B
| $11.1M | 0.02% |
+137,100
| New | +$9.98M |
|
|
FNSR
1159
DELISTED
Finisar Corp
FNSR
| $11.1M | 0.02% |
+481,095
| New | +$11M |
|
1160
Ecolab
ECL
$80.4B
| $11.1M | 0.02% |
+63,113
| New | +$10.3M |
|
1161
iShares MSCI Germany ETF
EWG
$1.72B
| $11.1M | 0.02% |
413,812
+359,606
| +663% | +$9.61M |
|
|
ADAP
1162
DELISTED
Adaptimmune Therapeutics
ADAP
| $11.1M | 0.02% |
2,588,740
+490,468
| +23% | +$2.28M |
|
|
VGR
1163
DELISTED
Vector Group Ltd.
VGR
| $11.1M | 0.02% |
1,527,119
-1,305,698
| -46% | -$9.71M |
|
1164
IBM
IBM
$218B
| $11.1M | 0.02% |
82,347
+28,431
| +53% | +$3.62M |
|
1165
PUT
Edwards Lifesciences
EW
$52.2B
| $11.1M | 0.02% |
174,000
+129,000
| +287% | +$7.36M |
|
1166
AAR Corp
AIR
$5.42B
| $11.1M | 0.02% |
+340,261
| New | +$12.3M |
|
1167
Yext
YEXT
$655M
| $11.1M | 0.02% |
505,787
+189,736
| +60% | +$3.44M |
|
|
CZR
1168
DELISTED
Caesars Entertainment Corporation
CZR
| $11M | 0.02% |
1,271,319
+842,726
| +197% | +$7.31M |
|
1169
Televisa
TV
$1.48B
| $11M | 0.02% |
997,645
+531,500
| +114% | +$6.31M |
|
|
AZUL
1170
DELISTED
Azul
AZUL
| $11M | 0.02% |
377,442
+94,492
| +33% | +$2.82M |
|
|
JBGS
1171
JBG SMITH
JBGS
$732M
| $11M | 0.02% |
266,515
+212,300
| +392% | +$8.33M |
|
1172
Altria Group
MO
$114B
| $11M | 0.02% |
191,782
-86,081
| -31% | -$4.4M |
|
|
HSKA
1173
DELISTED
Heska Corp
HSKA
| $11M | 0.02% |
129,399
+110,740
| +593% | +$9.99M |
|
|
MRTX
1174
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11M | 0.02% |
+150,000
| New | +$10.2M |
|
1175
Huntington Ingalls Industries
HII
$11.6B
| $11M | 0.02% |
53,006
-8,411
| -14% | -$1.72M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.